{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T12:07:46Z","timestamp":1786622866360,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsams.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Science and Medicine in Sport"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jsams.2023.08.179","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T05:23:16Z","timestamp":1692940996000},"page":"574-579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Is the use of performance and image enhancing drugs (PIEDs) in women an issue of concern? The findings from a stakeholder consultation"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4615-5078","authenticated-orcid":false,"given":"Matthew","family":"Dunn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Piatkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severine","family":"Lamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jsams.2023.08.179_bb0005","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2815","article-title":"Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: toxicological and psychopathological findings","volume":"37","author":"Piacentino","year":"2022","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"3","key":"10.1016\/j.jsams.2023.08.179_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2619","article-title":"The use of supplements and performance and image enhancing drugs in fitness settings: a exploratory cross-sectional investigation in the United Kingdom","volume":"32","author":"Mooney","year":"2017","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1016\/j.jsams.2023.08.179_bb0015","first-page":"1","article-title":"# Sponseredathlete: the marketing of image and performance enhancing drugs on Facebook and Instagram","author":"Gibbs","year":"2023","journal-title":"Trends Organ Crime"},{"issue":"2","key":"10.1016\/j.jsams.2023.08.179_bb0020","first-page":"131","article-title":"2, 4-Dinitrophenol, the inferno drug: a netnographic study of user experiences in the quest for leanness","volume":"22","author":"McVeigh","year":"2017","journal-title":"J Subst Abuse"},{"issue":"4","key":"10.1016\/j.jsams.2023.08.179_bb0025","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/01639625.2020.1806452","article-title":"\u2018Bali over the counter\u2019: exploring the overseas use and acquisition of anabolic-androgenic steroids","volume":"43","author":"Dunn","year":"2022","journal-title":"Deviant Behav"},{"issue":"2","key":"10.1016\/j.jsams.2023.08.179_bb0035","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/ap.12451","article-title":"Australia\u2019s Adonis: understanding what motivates young men\u2019s lifestyle choices for enhancing their appearance","volume":"55","author":"Piatkowski","year":"2020","journal-title":"Aust Psychol"},{"issue":"5","key":"10.1016\/j.jsams.2023.08.179_bb0040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.annepidem.2014.01.009","article-title":"The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis","volume":"24","author":"Sagoe","year":"2014","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.jsams.2023.08.179_bb0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2017.02.039","article-title":"History and epidemiology of anabolic androgens in athletes and non-athletes","volume":"464","author":"Kanayama","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jsams.2023.08.179_bb0050","series-title":"Gym culture, Identity, and Performance-enhancing Drugs: Tracing a Typology of Steroid Use","author":"Christiansen","year":"2020"},{"issue":"2","key":"10.1016\/j.jsams.2023.08.179_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.peh.2023.100249","article-title":"Investigating the capacity of Australian drug information systems to detect changes in anabolic-androgenic steroid use and harms","volume":"11","author":"Dunn","year":"2023","journal-title":"Perform Enhanc Health"},{"key":"10.1016\/j.jsams.2023.08.179_bb0060","series-title":"National Drug Strategy Household Survey 2019","author":"Australian Institute of Health and Welfare","year":"2020"},{"issue":"9","key":"10.1016\/j.jsams.2023.08.179_bb0065","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s40279-021-01477-y","article-title":"Doping prevalence in competitive sport: evidence synthesis with \u201cbest practice\u201d recommendations and reporting guidelines from the WADA Working Group on Doping Prevalence","volume":"51","author":"Gleaves","year":"2021","journal-title":"Sports Med (Auckland, NZ)"},{"issue":"4","key":"10.1016\/j.jsams.2023.08.179_bb0070","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1249\/01.mss.0000210194.56834.5d","article-title":"Anabolic androgenic steroids: a survey of 500 users","volume":"38","author":"Parkinson","year":"2006","journal-title":"Med Sci Sports Exerc"},{"issue":"7","key":"10.1016\/j.jsams.2023.08.179_bb0075","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1080\/10826084.2020.1726392","article-title":"Prevalence of performance-enhancing substance use and associated factors among Portuguese gym\/fitness users","volume":"55","author":"Tavares","year":"2020","journal-title":"Subst Use Misuse"},{"issue":"8","key":"10.1016\/j.jsams.2023.08.179_bb0080","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1096\/fj.08-105726","article-title":"Impaired skeletal muscle development and function in male, but not female, genomic androgen receptor knockout mice","volume":"22","author":"MacLean","year":"2008","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.jsams.2023.08.179_bb0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000012362","article-title":"Psychiatric and medical effects of anabolic-androgenic steroid use in women","volume":"69","author":"Gruber","year":"2000","journal-title":"Psychother Psychosom"},{"issue":"1","key":"10.1016\/j.jsams.2023.08.179_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40798-022-00548-2","article-title":"Recreational athletes\u2019 use of performance-enhancing substances: results from the first European randomized response technique survey","volume":"9","author":"Christiansen","year":"2023","journal-title":"Sports Med Open"},{"issue":"19","key":"10.1016\/j.jsams.2023.08.179_bb0095","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1001\/jama.1985.03350430083032","article-title":"Anabolic steroid use and perceived effects in ten weight-trained women athletes","volume":"253","author":"Strauss","year":"1985","journal-title":"JAMA"},{"key":"10.1016\/j.jsams.2023.08.179_bb0100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13011-016-0056-3","article-title":"Recruitment to doping and help-seeking behavior of eight female AAS users","volume":"11","author":"B\u00f6rjesson","year":"2016","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"3","key":"10.1016\/j.jsams.2023.08.179_bb0105","first-page":"246","article-title":"Anabolic\u2013androgenic steroid use among Brazilian women: an exploratory investigation","volume":"22","author":"Abrahin","year":"2017","journal-title":"J Subst Abuse"},{"issue":"6","key":"10.1016\/j.jsams.2023.08.179_bb0110","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1177\/2167479519896326","article-title":"\u201cYay, another lady starting a log!\u201d: women\u2019s fitness doping and the gendered space of an online doping forum","volume":"9","author":"Henning","year":"2021","journal-title":"Commun Sport"},{"issue":"2","key":"10.1016\/j.jsams.2023.08.179_bb0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/00050067.2021.2020074","article-title":"The relationship between psychosocial variables and drive for muscularity among male bodybuilding supplement users","volume":"57","author":"Piatkowski","year":"2022","journal-title":"Aust Psychol"},{"issue":"1","key":"10.1016\/j.jsams.2023.08.179_bb0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/dar.12085","article-title":"Steroid users and the unique challenge they pose to needle and syringe program (NSP) workers","volume":"33","author":"Dunn","year":"2014","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"10.1016\/j.jsams.2023.08.179_bb0125","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12954-023-00786-x","article-title":"Gendered perspectives on women\u2019s anabolic-androgenic steroid (AAS) usage practices","volume":"20","author":"Piatkowski","year":"2023","journal-title":"Harm Reduct J"},{"issue":"2","key":"10.1016\/j.jsams.2023.08.179_bb0130","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"key":"10.1016\/j.jsams.2023.08.179_bb0135","first-page":"1","article-title":"Is thematic analysis used well in health psychology? A critical review of published research, with recommendations for quality practice and reporting","author":"Braun","year":"2023","journal-title":"Health Psychol Rev"},{"key":"10.1016\/j.jsams.2023.08.179_bb0140","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.drugpo.2009.12.005","article-title":"Drug testing in sport: the attitudes and experiences of elite athletes","volume":"21","author":"Dunn","year":"2010","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.jsams.2023.08.179_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2021.126340","article-title":"Performance- and image-enhancing drug use in the community: use prevalence, user demographics and the potential role of wastewater-based epidemiology","volume":"419","author":"Shimko","year":"2021","journal-title":"J Hazard Mater"},{"issue":"6","key":"10.1016\/j.jsams.2023.08.179_bb0150","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/JSM.0b013e3181fb5370","article-title":"Women and anabolic steroids: an analysis of a dozen users","volume":"20","author":"Ip","year":"2010","journal-title":"Clin J Sport Med"},{"key":"10.1016\/j.jsams.2023.08.179_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102876","article-title":"Anabolic-androgenic steroid use among women - a qualitative study on experiences of masculinizing, gonadal and sexual effects","volume":"95","author":"Havnes","year":"2021","journal-title":"Int J Drug Policy"},{"issue":"4","key":"10.1016\/j.jsams.2023.08.179_bb0160","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/21674795211000657","article-title":"Challenging hegemony through narrative: centering women\u2019s experiences and establishing a sis-science culture through a women-only doping forum","volume":"10","author":"Andreasson","year":"2022","journal-title":"Commun Sport"},{"key":"10.1016\/j.jsams.2023.08.179_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108706","article-title":"The intersection of gender and drug use-related stigma: a mixed methods systematic review and synthesis of the literature","volume":"223","author":"Meyers","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jsams.2023.08.179_bb0170","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12954-017-0176-8","article-title":"Information sought, information shared: exploring performance and image enhancing drug user-facilitated harm reduction information in online forums","volume":"14","author":"Tighe","year":"2017","journal-title":"Harm Reduct J"},{"issue":"3","key":"10.1016\/j.jsams.2023.08.179_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.peh.2022.100223","article-title":"Understanding perspectives on harm reduction from performance and image enhancing drug consumers and health care providers","volume":"10","author":"Piatkowski","year":"2022","journal-title":"Perform Enhanc Health"}],"container-title":["Journal of Science and Medicine in Sport"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1440244023003833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1440244023003833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T17:56:28Z","timestamp":1761414988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1440244023003833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1440244023003833"],"URL":"https:\/\/doi.org\/10.1016\/j.jsams.2023.08.179","relation":{},"ISSN":["1440-2440"],"issn-type":[{"value":"1440-2440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is the use of performance and image enhancing drugs (PIEDs) in women an issue of concern? The findings from a stakeholder consultation","name":"articletitle","label":"Article Title"},{"value":"Journal of Science and Medicine in Sport","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsams.2023.08.179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of Sports Medicine Australia.","name":"copyright","label":"Copyright"}]}}